Salivary Gland Infection Market Report 2026
Download Free Sample Buy Now
Salivary Gland Infection Market Global Report 2026 Market Report Infographic Image
Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Salivary Gland Infection Market Report 2026

Global Outlook – By Diagnosis (Plain Radiography, Sialography, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Radionuclide Scintigraphy, High-resolution Ultrasonography, Other Diagnoses), By Treatment (Medications, Surgery, Aspiration, Home Care, Other Treatments), By End User (Hospitals And Clinics, Medical Research Centers, Academic Institutes, Other End User) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Salivary Gland Infection Market Overview

• Salivary Gland Infection market size has reached to $4.45 billion in 2025

• Expected to grow to $6.5 billion in 2030 at a compound annual growth rate (CAGR) of 7.8%

• Growth Driver: Impact Of Rising Oral Health Issues On Infection Rates

• Market Trend: Advancing Treatment With Minimally Invasive Innovations

• North America was the largest region in 2025.

What Is Covered Under Salivary Gland Infection Market?

Salivary gland infections are bacterial or viral infections that affect the salivary glands, leading to symptoms such as swelling, pain, and dry mouth. These infections occur in major glands such as the parotid, submandibular, and sublingual glands. They result from blockage, dehydration, or infections such as mumps.

The main diagnosis for the salivary gland infection are plain radiography, sialography, computed tomography (CT), magnetic resonance imaging (MRI), radionuclide scintigraphy, high-resolution ultrasonography, and other diagnostic techniques. Plain radiography is an imaging method that utilizes X-rays to produce images of internal body structures, including salivary glands, and is used to identify stones or calcifications in the glands. Treatment options encompass medications, surgery, aspiration, home care, and other therapies. These services are provided in hospitals and clinics, medical research centres, academic institutions, and other end-user settings.

Salivary Gland Infection Market Global Report 2026 Market Report bar graph

What Is The Salivary Gland Infection Market Size and Share 2026?

The salivary gland infection market size has grown strongly in recent years. It will grow from $4.45 billion in 2025 to $4.81 billion in 2026 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to increasing incidence of bacterial and viral salivary infections, improved access to diagnostic imaging, availability of broad-spectrum antibiotics, expansion of hospital-based ENT services, rising clinical awareness of gland disorders.

What Is The Salivary Gland Infection Market Growth Forecast?

The salivary gland infection market size is expected to see strong growth in the next few years. It will grow to $6.5 billion in 2030 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to increasing demand for advanced diagnostic accuracy, rising investments in ENT diagnostic tools, expansion of outpatient diagnostic services, growing focus on patient-centric treatment pathways, increasing integration of imaging and laboratory diagnostics. Major trends in the forecast period include increasing use of advanced imaging diagnostics, rising adoption of targeted antibiotic therapies, growing focus on early infection detection, expansion of minimally invasive treatment approaches, enhanced emphasis on comprehensive diagnostic pathways.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Salivary Gland Infection Market Segmentation

1) By Diagnosis: Plain Radiography, Sialography, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Radionuclide Scintigraphy, High-resolution Ultrasonography, Other Diagnoses

2) By Treatment: Medications, Surgery, Aspiration, Home Care, Other Treatments

3) By End User: Hospitals And Clinics, Medical Research Centers, Academic Institutes, Other End User

Subsegments:

1) By Plain Radiography: X-ray Of Salivary Glands, Sialography With X-ray

2) By Sialography: Conventional Sialography, Digital Subtraction Sialography (DSS)

3) By Computed Tomography (CT): Non-contrast CT, Contrast-enhanced CT

4) By Magnetic Resonance Imaging (MRI): MRI without contrast, MRI With contrast (Dynamic MRI)

5) By Radionuclide Scintigraphy: Planar Scintigraphy, SPECT (Single Photon Emission Computed Tomography)

6) By High-resolution Ultrasonography: Standard Ultrasonography, Doppler Ultrasonography

7) By Other Diagnoses: Fine Needle Aspiration (FNA) Biopsy, Endoscopy, Salivary Flow Test

What Are The Drivers Of The Salivary Gland Infection Market?

The rise in oral health issues is expected to drive the growth of salivary gland infections market going forward. Oral health issues include conditions such as tooth decay, gum infections, and other mouth-related problems. Poor oral hygiene, unhealthy eating habits, and inadequate dental care access are driving the rise in oral health problems. The rise in oral health issues increases the risk of salivary gland infections by promoting bacterial growth and blockages in the salivary ducts. For instance, in May 2024, according to the National Health Service (NHS), a UK-based government agency, in 2022-23, 32.5 million dental treatments were provided, reflecting a 23.2% increase compared to the previous year. Therefore, the rise in oral health issues is driving the growth of the salivary gland infections industry.

The growing demand for minimally invasive surgery is expected to drive the growth of salivary gland infections market going forward. Minimally invasive surgery is a method that uses small cuts and advanced tools to perform procedures with less pain, faster healing, and smaller scars than conventional surgery. The rise of minimally invasive surgery is driven by its advantages, such as less pain, faster recovery, and fewer risks, along with technological advancements such as robotics and laparoscopic equipment that improve precision and patient results. Minimally invasive surgery treats salivary gland infections by using small incisions and specialized tools to drain abscesses or remove blockages, reducing recovery time and complications. For instance, in June 2024, according to the American Society of Plastic Surgeons, a US-based non-profit organization, reported that in 2023, minimally invasive procedures saw a 7% increase compared to the previous year. Therefore, the growing demand for minimally invasive surgery is driving the salivary gland infections industry.

Key Players In The Global Salivary Gland Infection Market

Major companies operating in the salivary gland infection market are Pfizer Inc., Johnson And Johnson, Roche Holding AG, Merck And Co Inc, AbbVie Inc, AstraZeneca plc, Novartis AG, GSK plc, Eli Lilly And Company, FUJIFILM Holdings Corporation, Teva Pharmaceutical Industries Ltd, Boehringer Ingelheim GmbH, Astellas Pharma Inc, Sandoz International GmbH, Hikma Pharmaceuticals PLC, Lupin Pharmaceuticals Inc, Mylan NV, Zydus Cadila Healthcare Ltd, Sun Pharmaceutical Industries Ltd, Dr Reddys Laboratories Ltd, Cipla Limited, Sanofi SA, Bayer AG, Perrigo Company plc

Global Salivary Gland Infection Market Trends and Insights

Major companies operating in the salivary gland infections market are prioritizing technological advancements, particularly in minimally invasive procedures, to improve treatment outcomes, accelerate patient recovery, and enhance overall healthcare efficiency. Minimally invasive procedures involve smaller incisions and specialized tools, causing less tissue damage and promoting faster recovery. For instance, in March 2024, Amrita Hospital, an India-based healthcare institution, launched the Amrita Centre for minimally invasive salivary gland surgery, offering a groundbreaking treatment for salivary disorders through endoscopy, minimizing the need for surgery and preserving glandular function. The launch was highlighted by a two-day workshop showcasing expert demonstrations.

Need data on a specific region in this market?
Request Regional Data

Regional Outlook

North America was the largest region in the salivary gland infection market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Salivary Gland Infection Market?

The salivary gland infections market consists of revenues earned by entities by providing services such as ultrasound, rehabilitation therapy, and glandular duct dilation procedures. The market value includes the value of related goods sold by the service provider or included within the service offering. The salivary gland infections market includes sales of antibiotics, antiviral drugs, anti-inflammatory medications, and biocompatible stents. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Salivary Gland Infection Market Report 2026?

The salivary gland infection market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the salivary gland infection industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Salivary Gland Infection Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $4.81 billion
Revenue Forecast In 2035 $6.5 billion
Growth Rate CAGR of 8.1% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Diagnosis, Treatment, End User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Pfizer Inc., Johnson And Johnson, Roche Holding AG, Merck And Co Inc, AbbVie Inc, AstraZeneca plc, Novartis AG, GSK plc, Eli Lilly And Company, FUJIFILM Holdings Corporation, Teva Pharmaceutical Industries Ltd, Boehringer Ingelheim GmbH, Astellas Pharma Inc, Sandoz International GmbH, Hikma Pharmaceuticals PLC, Lupin Pharmaceuticals Inc, Mylan NV, Zydus Cadila Healthcare Ltd, Sun Pharmaceutical Industries Ltd, Dr Reddys Laboratories Ltd, Cipla Limited, Sanofi SA, Bayer AG, Perrigo Company plc
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Salivary Gland Infection Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Salivary Gland Infection Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Salivary Gland Infection Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Salivary Gland Infection Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Artificial Intelligence & Autonomous Intelligence

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Increasing Use Of Advanced Imaging Diagnostics

4.2.2 Rising Adoption Of Targeted Antibiotic Therapies

4.2.3 Growing Focus On Early Infection Detection

4.2.4 Expansion Of Minimally Invasive Treatment Approaches

4.2.5 Enhanced Emphasis On Comprehensive Diagnostic Pathways

5. Salivary Gland Infection Market Analysis Of End Use Industries

5.1 Hospitals And Clinics

5.2 Diagnostic Imaging Centers

5.3 Medical Research Centers

5.4 Academic Institutes

5.5 Ent Specialty Clinics

6. Salivary Gland Infection Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Salivary Gland Infection Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Salivary Gland Infection PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Salivary Gland Infection Market Size, Comparisons And Growth Rate Analysis

7.3. Global Salivary Gland Infection Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Salivary Gland Infection Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Salivary Gland Infection Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Salivary Gland Infection Market Segmentation

9.1. Global Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Plain Radiography, Sialography, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Radionuclide Scintigraphy, High-resolution Ultrasonography, Other Diagnoses

9.2. Global Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Medications, Surgery, Aspiration, Home Care, Other Treatments

9.3. Global Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals And Clinics, Medical Research Centers, Academic Institutes, Other End User

9.4. Global Salivary Gland Infection Market, Sub-Segmentation Of Plain Radiography, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

X-ray Of Salivary Glands, Sialography With X-ray

9.5. Global Salivary Gland Infection Market, Sub-Segmentation Of Sialography, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Conventional Sialography, Digital Subtraction Sialography (DSS)

9.6. Global Salivary Gland Infection Market, Sub-Segmentation Of Computed Tomography (CT), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Non-contrast CT, Contrast-enhanced CT

9.7. Global Salivary Gland Infection Market, Sub-Segmentation Of Magnetic Resonance Imaging (MRI), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

MRI without contrast, MRI With contrast (Dynamic MRI)

9.8. Global Salivary Gland Infection Market, Sub-Segmentation Of Radionuclide Scintigraphy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Planar Scintigraphy, SPECT (Single Photon Emission Computed Tomography)

9.9. Global Salivary Gland Infection Market, Sub-Segmentation Of High-resolution Ultrasonography, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Standard Ultrasonography, Doppler Ultrasonography

9.10. Global Salivary Gland Infection Market, Sub-Segmentation Of Other Diagnoses, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Fine Needle Aspiration (FNA) Biopsy, Endoscopy, Salivary Flow Test

10. Salivary Gland Infection Market Regional And Country Analysis

10.1. Global Salivary Gland Infection Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Salivary Gland Infection Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Salivary Gland Infection Market

11.1. Asia-Pacific Salivary Gland Infection Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Salivary Gland Infection Market, Segmentation By Diagnosis, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Salivary Gland Infection Market

12.1. China Salivary Gland Infection Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Salivary Gland Infection Market, Segmentation By Diagnosis, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Salivary Gland Infection Market

13.1. India Salivary Gland Infection Market, Segmentation By Diagnosis, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Salivary Gland Infection Market

14.1. Japan Salivary Gland Infection Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Salivary Gland Infection Market, Segmentation By Diagnosis, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Salivary Gland Infection Market

15.1. Australia Salivary Gland Infection Market, Segmentation By Diagnosis, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Salivary Gland Infection Market

16.1. Indonesia Salivary Gland Infection Market, Segmentation By Diagnosis, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Salivary Gland Infection Market

17.1. South Korea Salivary Gland Infection Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Salivary Gland Infection Market, Segmentation By Diagnosis, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Salivary Gland Infection Market

18.1. Taiwan Salivary Gland Infection Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Salivary Gland Infection Market, Segmentation By Diagnosis, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Salivary Gland Infection Market

19.1. South East Asia Salivary Gland Infection Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Salivary Gland Infection Market, Segmentation By Diagnosis, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Salivary Gland Infection Market

20.1. Western Europe Salivary Gland Infection Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Salivary Gland Infection Market, Segmentation By Diagnosis, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Salivary Gland Infection Market

21.1. UK Salivary Gland Infection Market, Segmentation By Diagnosis, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Salivary Gland Infection Market

22.1. Germany Salivary Gland Infection Market, Segmentation By Diagnosis, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Salivary Gland Infection Market

23.1. France Salivary Gland Infection Market, Segmentation By Diagnosis, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Salivary Gland Infection Market

24.1. Italy Salivary Gland Infection Market, Segmentation By Diagnosis, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Salivary Gland Infection Market

25.1. Spain Salivary Gland Infection Market, Segmentation By Diagnosis, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Salivary Gland Infection Market

26.1. Eastern Europe Salivary Gland Infection Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Salivary Gland Infection Market, Segmentation By Diagnosis, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Salivary Gland Infection Market

27.1. Russia Salivary Gland Infection Market, Segmentation By Diagnosis, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Salivary Gland Infection Market

28.1. North America Salivary Gland Infection Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Salivary Gland Infection Market, Segmentation By Diagnosis, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Salivary Gland Infection Market

29.1. USA Salivary Gland Infection Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Salivary Gland Infection Market, Segmentation By Diagnosis, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Salivary Gland Infection Market

30.1. Canada Salivary Gland Infection Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Salivary Gland Infection Market, Segmentation By Diagnosis, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Salivary Gland Infection Market

31.1. South America Salivary Gland Infection Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Salivary Gland Infection Market, Segmentation By Diagnosis, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Salivary Gland Infection Market

32.1. Brazil Salivary Gland Infection Market, Segmentation By Diagnosis, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Salivary Gland Infection Market

33.1. Middle East Salivary Gland Infection Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Salivary Gland Infection Market, Segmentation By Diagnosis, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Salivary Gland Infection Market

34.1. Africa Salivary Gland Infection Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Salivary Gland Infection Market, Segmentation By Diagnosis, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Salivary Gland Infection Market Regulatory and Investment Landscape

36. Salivary Gland Infection Market Competitive Landscape And Company Profiles

36.1. Salivary Gland Infection Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Salivary Gland Infection Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Salivary Gland Infection Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Johnson And Johnson Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Merck And Co Inc Overview, Products and Services, Strategy and Financial Analysis

36.3.5. AbbVie Inc Overview, Products and Services, Strategy and Financial Analysis

37. Salivary Gland Infection Market Other Major And Innovative Companies

AstraZeneca plc, Novartis AG, GSK plc, Eli Lilly And Company, FUJIFILM Holdings Corporation, Teva Pharmaceutical Industries Ltd, Boehringer Ingelheim GmbH, Astellas Pharma Inc, Sandoz International GmbH, Hikma Pharmaceuticals PLC, Lupin Pharmaceuticals Inc, Mylan NV, Zydus Cadila Healthcare Ltd, Sun Pharmaceutical Industries Ltd, Dr Reddys Laboratories Ltd

38. Global Salivary Gland Infection Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Salivary Gland Infection Market

40. Salivary Gland Infection Market High Potential Countries, Segments and Strategies

40.1 Salivary Gland Infection Market In 2030 - Countries Offering Most New Opportunities

40.2 Salivary Gland Infection Market In 2030 - Segments Offering Most New Opportunities

40.3 Salivary Gland Infection Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Salivary Gland Infection Market, Overview Of Key Products - Product Examples
  • Table 2: Global Salivary Gland Infection Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Salivary Gland Infection Market, Supply Chain Analysis
  • Table 4: Global Salivary Gland Infection Market, Major Raw Material Providers
  • Table 5: Global Salivary Gland Infection Market, Major Resource Providers
  • Table 6: Global Salivary Gland Infection Market, Major Manufacturers (Suppliers)
  • Table 7: Global Salivary Gland Infection Market, Major Distributors And Channel Partners
  • Table 8: Global Salivary Gland Infection Market, Key Technologies & Future Trends
  • Table 9: Global Salivary Gland Infection Market, Major Trends
  • Table 10: Global Salivary Gland Infection Market, Major End Users
  • Table 11: Global Salivary Gland Infection Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Salivary Gland Infection Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Salivary Gland Infection Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Salivary Gland Infection Market - TAM, US$ Billion, 2025
  • Table 15: Global Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Salivary Gland Infection Market, Sub-Segmentation Of Plain Radiography, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Salivary Gland Infection Market, Sub-Segmentation Of Sialography, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Salivary Gland Infection Market, Sub-Segmentation Of Computed Tomography (CT), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Salivary Gland Infection Market, Sub-Segmentation Of Magnetic Resonance Imaging (MRI), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Salivary Gland Infection Market, Sub-Segmentation Of Radionuclide Scintigraphy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Salivary Gland Infection Market, Sub-Segmentation Of High-resolution Ultrasonography, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Global Salivary Gland Infection Market, Sub-Segmentation Of Other Diagnoses, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Global Salivary Gland Infection Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Global Salivary Gland Infection Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: Asia-Pacific, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: Asia-Pacific, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: Asia-Pacific, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: China, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: China, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: China, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: India, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: India, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: India, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Japan, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Japan, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Japan, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Australia, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Australia, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Australia, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Indonesia, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: Indonesia, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Indonesia, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: South Korea, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: South Korea, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South Korea, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: Taiwan, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: Taiwan, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Taiwan, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: South East Asia, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: South East Asia, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: South East Asia, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: Western Europe, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: Western Europe, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Western Europe, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: UK, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: UK, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: UK, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Germany, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Germany, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Germany, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: France, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: France, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: France, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Italy, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Italy, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Italy, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Spain, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Spain, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Spain, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Eastern Europe, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Eastern Europe, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Eastern Europe, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: Russia, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: Russia, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: Russia, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: North America, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: North America, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: North America, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: USA, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: USA, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: USA, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: Canada, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: Canada, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Canada, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: South America, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: South America, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: South America, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Brazil, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Brazil, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Brazil, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Middle East, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Middle East, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Middle East, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Africa, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 97: Africa, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 98: Africa, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 99: Global Salivary Gland Infection Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 100: Global Salivary Gland Infection Market - Company Scoring Matrix
  • Table 101: Pfizer Inc. Financial Performance
  • Table 102: Johnson And Johnson Financial Performance
  • Table 103: Roche Holding AG Financial Performance
  • Table 104: Merck And Co Inc Financial Performance
  • Table 105: AbbVie Inc Financial Performance
  • Table 106: Global Salivary Gland Infection Market, Competitive Benchmarking (In USD Billions)
  • Table 107: Global Salivary Gland Infection Market, Competitive Dashboard
  • Table 108: Global Salivary Gland Infection Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 109: Global, Salivary Gland Infection Market Size Gain ($ Billion), Segmentation By Diagnosis, 2025 – 2030
  • Table 110: Global, Salivary Gland Infection Market Size Gain ($ Billion), Segmentation By Treatment, 2025 – 2030
  • Table 111: Global, Salivary Gland Infection Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

List Of Figures

    Figure 1: Global Salivary Gland Infection Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Salivary Gland Infection Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Salivary Gland Infection Market, Supply Chain Analysis
  • Figure 4: Global Salivary Gland Infection Market, Major Raw Material Providers
  • Figure 5: Global Salivary Gland Infection Market, Major Resource Providers
  • Figure 6: Global Salivary Gland Infection Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Salivary Gland Infection Market, Major Distributors And Channel Partners
  • Figure 8: Global Salivary Gland Infection Market, Key Technologies & Future Trends
  • Figure 9: Global Salivary Gland Infection Market, Major Trends
  • Figure 10: Global Salivary Gland Infection Market, Major End Users
  • Figure 11: Global Salivary Gland Infection Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Salivary Gland Infection Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Salivary Gland Infection Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Salivary Gland Infection Market - TAM, US$ Billion, 2025
  • Figure 15: Global Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Salivary Gland Infection Market, Sub-Segmentation Of Plain Radiography, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Salivary Gland Infection Market, Sub-Segmentation Of Sialography, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Salivary Gland Infection Market, Sub-Segmentation Of Computed Tomography (CT), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Salivary Gland Infection Market, Sub-Segmentation Of Magnetic Resonance Imaging (MRI), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Salivary Gland Infection Market, Sub-Segmentation Of Radionuclide Scintigraphy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Salivary Gland Infection Market, Sub-Segmentation Of High-resolution Ultrasonography, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Global Salivary Gland Infection Market, Sub-Segmentation Of Other Diagnoses, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Global Salivary Gland Infection Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Global Salivary Gland Infection Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: Asia-Pacific, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: Asia-Pacific, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: Asia-Pacific, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: China, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: China, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: China, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: India, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: India, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: India, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Japan, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Japan, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Japan, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Australia, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Australia, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Australia, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Indonesia, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: Indonesia, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Indonesia, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: South Korea, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: South Korea, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South Korea, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: Taiwan, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: Taiwan, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Taiwan, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: South East Asia, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: South East Asia, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: South East Asia, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: Western Europe, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: Western Europe, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Western Europe, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: UK, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: UK, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: UK, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Germany, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Germany, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Germany, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: France, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: France, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: France, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Italy, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Italy, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Italy, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Spain, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Spain, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Spain, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Eastern Europe, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Eastern Europe, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Eastern Europe, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: Russia, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: Russia, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: Russia, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: North America, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: North America, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: North America, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: USA, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: USA, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: USA, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: Canada, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: Canada, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Canada, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: South America, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: South America, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: South America, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Brazil, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Brazil, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Brazil, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Middle East, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Middle East, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Middle East, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Africa, Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 97: Africa, Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 98: Africa, Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 99: Global Salivary Gland Infection Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 100: Global Salivary Gland Infection Market - Company Scoring Matrix
  • Figure 101: Pfizer Inc. Financial Performance
  • Figure 102: Johnson And Johnson Financial Performance
  • Figure 103: Roche Holding AG Financial Performance
  • Figure 104: Merck And Co Inc Financial Performance
  • Figure 105: AbbVie Inc Financial Performance
  • Figure 106: Global Salivary Gland Infection Market, Competitive Benchmarking (In USD Billions)
  • Figure 107: Global Salivary Gland Infection Market, Competitive Dashboard
  • Figure 108: Global Salivary Gland Infection Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 109: Global, Salivary Gland Infection Market Size Gain ($ Billion), Segmentation By Diagnosis, 2025 – 2030
  • Figure 110: Global, Salivary Gland Infection Market Size Gain ($ Billion), Segmentation By Treatment, 2025 – 2030
  • Figure 111: Global, Salivary Gland Infection Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

Strategic Report on Gender Reassignment Surgery Market: Growth Opportunities and Emerging Challenges

Read More About Strategic Report on Gender Reassignment Surgery Market: Growth Opportunities and Emerging Challenges

In-Depth Health Check-Up Market Report: Business Trends, Growth Factors, and Forecast to 2029

Read More About In-Depth Health Check-Up Market Report: Business Trends, Growth Factors, and Forecast to 2029

Global Insights: Healthcare Digital Experience Platform Market Expected to Surpass $4.34 Billion by 2029

Read More About Global Insights: Healthcare Digital Experience Platform Market Expected to Surpass $4.34 Billion by 2029

2025 Healthcare Information Technology (IT) Outsourcing Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Healthcare Information Technology (IT) Outsourcing Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Read More About A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Read More About Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Explore the latest trends, growth insights, and forecasts in the Key Trend Shaping The Ophthalmology Medical Service Market.

Read More About Explore the latest trends, growth insights, and forecasts in the Key Trend Shaping The Ophthalmology Medical Service Market.

Artificial Saliva Market Report 2026 - Global Outlook – By Product (Oral Spray, Oral Solution, Oral Liquid, Dissolving Tablets, Gel, Powder), By Distribution Channel (Supermarkets, Hypermarkets, Other Distribution Channe...

COVID-19 Saliva Screening Test Potential Market Report 2026 - Global Outlook – By Location (Travel Stations, Sports Arenas, Entertainment Venues, Corporate Campus Environments, Universities And Colleges, Factories, Other...

Oral Hygiene Market Report 2026 - Global Outlook – By Product (Toothpaste, Toothbrushes And Accessories, Mouthwash And Rinses, Dental Accessories And Ancillaries, Denture Products, Dental Prosthesis Cleaning Solutions, O...

Ear Infection Market Report 2026 - Global Outlook – By Type (Middle Ear, Outer Ear, Inner Ear), By Pathogen (Bacteria, Virus), By Treatment Type (Medication, Antibiotics, Analgesics, Antiviral, Surgery, Other Treatment T...

Mouthwash Market Report 2026 - Global Outlook – By Type (Therapeutic, Cosmetic, Anti-Septic, Other Types), By Flavor (Active Salt, Mint, Fresh Tea, Other Flavors), By Sales (Modern Trade, Departmental Store, Drug Stores,...

Foot And Mouth Disease Vaccine Market Report 2026 - Global Outlook – By Vaccine Type (Conventional Vaccines, Oil Based Vaccines, Aluminum Hydroxide Or Saponin Based Vaccines, Emergency Vaccines), By Animal Type (Cattle, ...

Dental Flap Surgery Market Report 2026 - Global Outlook – By Flap Type (Trapezoidal Flap, Triangular Flap, Envelope Flap, Semilunar Flap, Pedicle Flap), By Incision Type (Horizontal, Vertical), By Technique (Modified Wid...

Oral Care Market Report 2026 - Global Outlook – By Product Type (Toothpaste, Mouth Wash And Rinse, Teeth Whitening, Dental Floss, Tooth Brush, Orthodontic Wax), By Distribution Channel (Store-Based, Non-Store-Based), By ...

Frequently Asked Questions

The Salivary Gland Infection market was valued at $4.45 billion in 2025, increased to $4.81 billion in 2026, and is projected to reach $6.5 billion by 2030.

The global Salivary Gland Infection market is expected to grow at a CAGR of 7.8% from 2026 to 2035 to reach $6.5 billion by 2035.

Some Key Players in the Salivary Gland Infection market Include, Pfizer Inc., Johnson And Johnson, Roche Holding AG, Merck And Co Inc, AbbVie Inc, AstraZeneca plc, Novartis AG, GSK plc, Eli Lilly And Company, FUJIFILM Holdings Corporation, Teva Pharmaceutical Industries Ltd, Boehringer Ingelheim GmbH, Astellas Pharma Inc, Sandoz International GmbH, Hikma Pharmaceuticals PLC, Lupin Pharmaceuticals Inc, Mylan NV, Zydus Cadila Healthcare Ltd, Sun Pharmaceutical Industries Ltd, Dr Reddys Laboratories Ltd, Cipla Limited, Sanofi SA, Bayer AG, Perrigo Company plc .

Major trend in this market includes: Advancing Treatment With Minimally Invasive Innovations. For further insights on this market. request a sample here

North America was the largest region in the salivary gland infection market in 2025. The regions covered in the salivary gland infection market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us